Barbara Leuchs

2.8k total citations
51 papers, 1.8k citations indexed

About

Barbara Leuchs is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Barbara Leuchs has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 22 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Barbara Leuchs's work include Virus-based gene therapy research (45 papers), CAR-T cell therapy research (14 papers) and RNA Interference and Gene Delivery (11 papers). Barbara Leuchs is often cited by papers focused on Virus-based gene therapy research (45 papers), CAR-T cell therapy research (14 papers) and RNA Interference and Gene Delivery (11 papers). Barbara Leuchs collaborates with scholars based in Germany, France and United States. Barbara Leuchs's co-authors include Jean Rommelaere, Jürgen A. Kleinschmidt, Oliver J. Müller, Hugo A. Katus, Florian Sonntag, Roger Fischer, Sven T. Pleger, Zahari Raykov, Karsten Geletneky and Jacek Hajda and has published in prestigious journals such as PLoS ONE, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Barbara Leuchs

50 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Leuchs Germany 22 1.1k 942 470 343 307 51 1.8k
Brad E. Hoffman United States 25 972 0.9× 965 1.0× 552 1.2× 219 0.6× 167 0.5× 35 2.0k
Markus Hildinger Germany 23 1.3k 1.2× 1.7k 1.8× 411 0.9× 259 0.8× 131 0.4× 31 2.2k
Rénald Gilbert Canada 24 727 0.6× 1.1k 1.1× 260 0.6× 216 0.6× 154 0.5× 67 1.5k
A. Bout Netherlands 26 1.3k 1.1× 1.2k 1.3× 610 1.3× 273 0.8× 125 0.4× 42 1.9k
Dipongkor Saha United States 24 887 0.8× 457 0.5× 804 1.7× 300 0.9× 104 0.3× 47 1.7k
Abraham Scaria United States 22 1.4k 1.2× 1.7k 1.8× 392 0.8× 300 0.9× 87 0.3× 54 2.4k
Denise E. Sabatino United States 25 1.8k 1.6× 1.8k 1.9× 739 1.6× 279 0.8× 180 0.6× 53 2.8k
Gudrun Schiedner Germany 19 1.7k 1.5× 1.7k 1.8× 490 1.0× 345 1.0× 130 0.4× 31 2.3k
Julio Sanmiguel United States 21 1.1k 1.0× 1.1k 1.2× 263 0.6× 264 0.8× 294 1.0× 28 1.7k
Paul Fields United States 21 1.1k 1.0× 1.9k 2.0× 732 1.6× 206 0.6× 209 0.7× 44 2.7k

Countries citing papers authored by Barbara Leuchs

Since Specialization
Citations

This map shows the geographic impact of Barbara Leuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Leuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Leuchs more than expected).

Fields of papers citing papers by Barbara Leuchs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Leuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Leuchs. The network helps show where Barbara Leuchs may publish in the future.

Co-authorship network of co-authors of Barbara Leuchs

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Leuchs. A scholar is included among the top collaborators of Barbara Leuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Leuchs. Barbara Leuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Marcus, et al.. (2023). Stability and safety key factors of the oncolytic protoparvovirus H-1 from manufacturing to human application. Applied Microbiology and Biotechnology. 107(15). 4777–4787.
2.
Müller, Marcus, et al.. (2021). Upstream process optimization and micro- and macrocarrier screening for large-scale production of the oncolytic H-1 protoparvovirus. Applied Microbiology and Biotechnology. 105(24). 9113–9124. 2 indexed citations
3.
Bauer, Ralf, Andreas Jungmann, Barbara Leuchs, et al.. (2018). Various effects of AAV9-mediated βARKct gene therapy on the heart in dystrophin-deficient (mdx) mice and δ-sarcoglycan-deficient (Sgcd-/-) mice. Neuromuscular Disorders. 29(3). 231–241. 10 indexed citations
4.
5.
Jungmann, Andreas, Barbara Leuchs, Hugo A. Katus, Jean Rommelaere, & Oliver J. Müller. (2017). Protocol for efficient generation and characterization of adeno-associated viral (AAV) vectors. Human Gene Therapy Methods. 5 indexed citations
6.
Leuchs, Barbara, et al.. (2017). A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles. Applied Microbiology and Biotechnology. 101(8). 3143–3152. 10 indexed citations
7.
Jungmann, Andreas, Barbara Leuchs, Jean Rommelaere, Hugo A. Katus, & Oliver J. Müller. (2017). Protocol for Efficient Generation and Characterization of Adeno-Associated Viral Vectors. Human Gene Therapy Methods. 28(5). 235–246. 46 indexed citations
8.
Leuchs, Barbara, et al.. (2015). Standardized large-scale H-1PV production process with efficient quality and quantity monitoring. Journal of Virological Methods. 229. 48–59. 10 indexed citations
9.
Alonso, Angelika, Eileen Reinz, Barbara Leuchs, et al.. (2014). Focal delivery of AAV2/1-transgenes into the rat brain by localized ultrasound-induced BBB Opening. Annals of Neurosciences. 21(1). 22–22. 18 indexed citations
10.
Jones, Allan, Kilian Friedrich, Maria Rohm, et al.. (2013). TSC22D4 is a molecular output of hepatic wasting metabolism. EMBO Molecular Medicine. 5(2). 294–308. 47 indexed citations
11.
12.
Nieto, Karen, Christiane Stahl‐Hennig, Barbara Leuchs, et al.. (2012). Intranasal Vaccination with AAV5 and 9 Vectors Against Human Papillomavirus Type 16 in Rhesus Macaques. Human Gene Therapy. 23(7). 733–741. 40 indexed citations
13.
Moehler, Markus, Susanne Roth, Barbara Leuchs, et al.. (2011). Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1. BMC Cancer. 11(1). 464–464. 32 indexed citations
14.
Osen, Wolfram, Sabine Soltek, Mingxia Song, et al.. (2010). Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries. PLoS ONE. 5(11). e14137–e14137. 16 indexed citations
15.
Lacroix, Jeannine, Barbara Leuchs, Junwei Li, et al.. (2010). Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells. International Journal of Cancer. 127(5). 1230–1239. 33 indexed citations
16.
Ying, Yanling, Oliver J. Müller, Barbara Leuchs, et al.. (2010). Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library. Gene Therapy. 17(8). 980–990. 53 indexed citations
17.
Angelova, Assia L., Marc Aprahamian, Svitlana P. Grekova, et al.. (2009). Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV. Clinical Cancer Research. 15(2). 511–519. 81 indexed citations
18.
Raykov, Zahari, et al.. (2008). Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity. International Journal of Cancer. 122(12). 2880–2884. 39 indexed citations
19.
Müller, Oliver J., Barbara Leuchs, Sven T. Pleger, et al.. (2006). Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovascular Research. 70(1). 70–78. 125 indexed citations
20.
Kehl, Timo, et al.. (2006). Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells. Cell and Tissue Research. 325(3). 423–436. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brad E. Hoffman Breakdown of academic impact, for papers by Markus Hildinger Breakdown of academic impact, for papers by Rénald Gilbert Breakdown of academic impact, for papers by A. Bout Breakdown of academic impact, for papers by Dipongkor Saha Breakdown of academic impact, for papers by Abraham Scaria Breakdown of academic impact, for papers by Denise E. Sabatino Breakdown of academic impact, for papers by Gudrun Schiedner Breakdown of academic impact, for papers by Julio Sanmiguel Breakdown of academic impact, for papers by Paul Fields
Rankless by CCL
2026